证券记录 · 已归档季度
REPL
Replimune Group, Inc. · Healthcare · Biotechnology
11被追踪持有人
+1Δ持有人
14.48M持有股份
$158.71M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 -9.5% ·
净新建仓位 +9.1%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 75 | +2 | 45.55M | $503.98M | +13 | −11 |
| Q1 2026 | 75 | +4 | 41.32M | $315.89M | +10 | −6 |
| Q4 2025 | 71 | +3 | 45.45M | $441.76M | +3 | — |
| Q3 2025 | 15 | -4 | 32.26M | $135.16M | — | −4 |
| Q2 2025 | 16 | 0 | 29.86M | $277.39M | — | — |
| Q1 2025 | 13 | 0 | 20.78M | $202.64M | — | — |
| Q4 2024 | 13 | +1 | 19.63M | $237.78M | +2 | −1 |
| Q3 2024 | 11 | +1 | 14.48M | $158.71M | +1 | — |
| Q2 2024 | 10 | — | 16.01M | $144.07M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 9.88M | +7.0% | $108.28M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 9.88M | +7.0% | $108.28M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.43M | +17.9% | $15.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.43M | +17.9% | $15.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.15M | -63.0% | $12.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 867.68K | -6.9% | $9.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 867.68K | -6.9% | $9.51M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Norges Bank ✦ (被动) | 379.40K | -17.5% | $4.16M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 242.40K | -40.2% | $2.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 242.40K | -40.2% | $2.66M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 179.24K | -13.4% | $1.96M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 135.78K | -36.8% | $1.49M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 107.74K | -25.8% | $1.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 77.66K | 0.0% | $851,186 | 0.0% | Held | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 27.79K | 新增 | $304,534 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 27.79K | 新增 | $304,534 | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 27.79K | 新增 | $304,534 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| AQR Capital Management | $304,534 | 0.0% |
| AQR Capital Management | $304,534 | 0.0% |
| AQR Capital Management | $304,534 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 70.00K 股份, $535 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
Hill Emily Luisa
Officer · 9.26K 股 · $132,176
Aug 10
Hill Emily Luisa
Officer · 11.45K 股 · $148,481
Aug 10
Patel Sushil
Officer, Director · 39.34K 股 · $510,253
Aug 10
Schwendenman Andrew
Officer · 7.63K 股 · $98,987
Aug 10
Xynos Konstantinos
Officer · 11.45K 股 · $148,468
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — Ridgeback Capital Investments L.P.
Aug 11
SC 13D/A — BAKER BROS. ADVISORS LP
11.8% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 10
SC 13G — GOLDMAN SACHS GROUP INC
Aug 07
SC 13G — STATE STREET CORP
Aug 06
SC 13G/A — MONTANOVA CAPITAL, LLC
May 21
SC 13G — Ridgeback Capital Investments L.P.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据